Based on the collected data, we found that SNHG25 silence inhibited in vivo tumor growth, accompanied by reduced tumor volume and weight, but such phenomena were counteracted to varying degrees after synchronous overexpression of SNORA50C or HDAC1 (Fig. 7A–D). This evidence concerns the gene HDAC1 and neoplasm.